U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699276) titled 'Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin' on July 07.
Brief Summary: A phase II study evaluating dexamethasone sparing regimen with olanzapine and palonosetron for patients receiving high dose cisplatin to prevent chemotherapy induced nausea and vomiting
Study Start Date: Feb. 10
Study Type: INTERVENTIONAL
Condition:
Cancer (Solid Tumors)
Vomiting
Cisplatin
Olanzapine
Intervention:
DRUG: dexamethasone sparing
omit dexamethasone on day 2-4
Recruitment Status: RECRUITING
Sponsor: Mahidol University
Disclaimer: Curated by HT Syndication....